CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IIa Safety and Tolerability Study to Investigate the Effect on Sleep of 3 Doses of AZD5213 and Placebo in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment During 4 Weeks of Treatment, Placebo-Controlled

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01548287
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:18.188548+00:00
Published At: 2016-12-05T00:00:00+00:00
Record Updated At: 2017-02-07
Results Posted At: 2016-12-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mild Cognitive Impairment", "Mild Alzheimer\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-02-07"
protocolSection.identificationModule.nctId: "NCT01548287"
protocolSection.identificationModule.officialTitle: "A Phase IIa Safety and Tolerability Study to Investigate the Effect on Sleep of 3 Doses of AZD5213 and Placebo in Patients With Mild Alzheimer\u0027s Disease and Mild Cognitive Impairment During 4 Weeks of Treatment, Placebo-Controlled"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-12-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.